Trade Mark Journal No.2025/021 23 May 2025
UK00004199922 7 May 2025 (5)

International priority date claimed: 26 November 2024
(United States of America)
(98873662)
- Class 5
- Pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations containing epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions; pharmaceutical preparations containing prodrugs of epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions.
Aquestive Therapeutics, Inc.
Representative: Ashfords LLP